Term
In cholinergic transmission, ACh is found in: |
|
Definition
Ganglia Postganglionic parasympathetic nerve ending Neuromuscular junction |
|
|
Term
Muscarinic receptors are this time of receptor: |
|
Definition
G-protein Coupled Receptor |
|
|
Term
These muscarinic receptors are found in the CNS, peripheral neurons, and gastric parietal cells. They are responsible for mediating the secretion of acid in the stomach. |
|
Definition
|
|
Term
This type of muscarinic receptor is mainly found in the heart and is responsible for decreasing contractility of the heart. |
|
Definition
|
|
Term
This type of muscarinic receptor controls glandular secretions and contraction of visceral smooth muscles. |
|
Definition
|
|
Term
These muscarinic receptors are found centralized in the CNS |
|
Definition
M4 and M5 muscarinic receptors |
|
|
Term
These muscarinic receptors act through the inositol phosphate pathway. |
|
Definition
M1, M3, M5 muscarinic receptors |
|
|
Term
These muscarinic receptors act through inhibiting adenylate cyclase. |
|
Definition
M2 and M4 muscarinic receptors |
|
|
Term
Binding of ACh and this type of receptor elicits stimulation of the autonomic ganglia, stimulation of voluntary muscles, and secretion of epinephrine from the adrenal medulla. |
|
Definition
|
|
Term
Binding of ACh with this type of receptor elicits parasympathetic stimulation. |
|
Definition
|
|
Term
This enzyme is responsible for ACh uptake. |
|
Definition
|
|
Term
This enzyme synthesizes ACh |
|
Definition
Choline Acetyltransferase (ChAT) |
|
|
Term
This transporter is responsible for loading ACh into vesicles. |
|
Definition
Vesicular Acetylcholine Transporter (VAChT) |
|
|
Term
This enzyme is responsible for the hydrolysis of ACh yielding choline and acetate. |
|
Definition
Acetylcholinesterase (AChE) |
|
|
Term
ACh release is dependent on this cation. |
|
Definition
|
|
Term
This states that neurotransmitters are released in small elementary packets or quanta that are uniform in size. |
|
Definition
|
|
Term
This is caused by the influx of Na+ through nAChR and depolarizes the muscle fibers. |
|
Definition
|
|
Term
This is caused by the influx of Na+ through voltage gated Na+ channels. |
|
Definition
|
|
Term
This non-depolarizing muscle relaxant works by blocking the binding of ACh to nAChR on the post synaptic membrane of the neuromuscular junction. It is commonly used in South American poison darts. |
|
Definition
|
|
Term
This neurotoxin binds irreversibly to the nAChR, i.e. it is an irreversible antagonist for nAChR. It is a component of the venom of the Taiwanese banded krait. |
|
Definition
|
|
Term
These neuromuscular blocking agents (muscle relaxants) are competitive reversible antagonists of nACh/nAChR. They block access of ACh to nAChR. |
|
Definition
Non-depolarizing muscle relaxants |
|
|
Term
These neuromuscular blocking agents (muscle relaxants) work as excessive depolarizing agonists that maintain endplate membrane depolarization. They prevent the transmission of another action potential. |
|
Definition
Depolarizing muscle relaxants |
|
|
Term
d-tubocurarine, atracurium, and vecuronium are examples of: |
|
Definition
Non-depolarizing muscle relaxants |
|
|
Term
d-tubocurarine, atracurium, and vecuronium are used: |
|
Definition
In conjunction with anesthesia for surgery. They help to relax tracheal muscles for endotracheal intubation. |
|
|
Term
Succinylcholine is an example of: |
|
Definition
Depolarizing muscle relaxant |
|
|
Term
|
Definition
With anesthesia to aid endotracheal intubation during surgery |
|
|
Term
Tubocurarine and pancuronium are examples of: |
|
Definition
Non-depolarizing muscle relaxants |
|
|
Term
These blocking agents work by blocking endplate potential thus blocking initiation of action potential in skeletal muscle. |
|
Definition
Non-depolarizing muscle relaxants |
|
|
Term
Non-depolarizing muscle relaxants have less side effects because: |
|
Definition
They are polar molecules that do not cross the BBB |
|
|
Term
These drugs are sometimes used to increase levels of ACh. |
|
Definition
|
|
Term
State the order of paralysis for non-depolarizing muscle relaxants. |
|
Definition
1. Extraocular (causes double vision) 2. Extremeties: head, neck, face, hands, and feet 3. Abdomen, arms, and legs 4. Eyeblink 5. Respiratory and diaphragm (diaphragm paralysis causes death) |
|
|
Term
State some of the side effects of non-depolarizing muscle relaxants. |
|
Definition
Fall in arterial pressure (due to ganglionic blocking) Bronchospasm (due to release of histamine from mast cells) Tachycardia (due to blockade of mAChR by high drug concentrations) |
|
|
Term
Depolarizing blocking agents work by these two mechanisms: |
|
Definition
Phase I Block Phase II Block |
|
|
Term
State some of the side effects of depolarizing blocking agents: |
|
Definition
Bradycardia (due to direct action of succinylcholine) Hyperkalemia (especially in burn or trauma pts) Increased intraocular pressure Prolonged paralysis Malignant hyperthermia |
|
|
Term
Only _______ is inhibited by anticholinesterase drugs. |
|
Definition
|
|
Term
Fasiculation, or disorganized twitching, is caused by: |
|
Definition
Depolarizing blocking agents |
|
|
Term
Tetanic fade is related to ________ blocking agents. |
|
Definition
|
|
Term
ACh, carbachol, bethanechol, and pilocarpine are examples of muscarinic ________. |
|
Definition
|
|
Term
Pilocarpine, carbachol, and bethanechol are used to treat: |
|
Definition
|
|
Term
Muscarinic agonists cause this/these effect(s) on the cardiovascular system: |
|
Definition
Decrease heart rate, decrease cardiac output |
|
|
Term
Muscarinic agnoists cause this/these effect(s) on smooth muscle: |
|
Definition
Increase peristalic GI activity, contraction of bladder and bronchiole smooth muscle |
|
|
Term
Muscarinic agnoists cause this/these effect(s) on the eyes: |
|
Definition
Constrict sphincter and ciliary muscle, which decrease pupil size and accomodate near vision respectively
|
|
|
Term
Muscarinic agonists cause this/these effect(s) on CNS: |
|
Definition
If the agonist penetrates the BBB: Activate M1 receptor, cause tremor, hypothermia, increase locomotor activity |
|
|
Term
Pilocarpine is used primarily for: |
|
Definition
|
|
Term
Bethanechol is used primarily for: |
|
Definition
|
|
Term
Carbachol and pilocarpine cause _____, which causes a _____. |
|
Definition
Miosis, Decrease in intraocular pressure |
|
|
Term
Atropine, hyoscine, ipratroprium are examples of: |
|
Definition
|
|
Term
Tropicamide and cyclopentolate are _________ that are used for ________. |
|
Definition
Muscarinic antagonists, pupil dilation |
|
|
Term
Muscarinic antagonists cause this/these effect(s) on secretions: |
|
Definition
|
|
Term
Muscarinic antagonists cause this/these effect(s) on heart rate: |
|
Definition
|
|
Term
Muscarinic antagonists cause this/these effect(s) on eyes: |
|
Definition
Pupil dilation, reduction in near vision, increase intraocular pressure |
|
|
Term
Muscarinic antagonists cause this/these effect(s) on GI tract: |
|
Definition
|
|
Term
Muscarinic antagonists cause this/these effect(s) on smooth muscles: |
|
Definition
Relaxation of bronchial, ciliary, pupillary smooth muscles |
|
|
Term
Muscarinic antagonists cause this/these effect(s) on CNS: |
|
Definition
Excitatory effects, agitation, restlessness, disorientation |
|
|
Term
Atropine is clinically used for: |
|
Definition
Adjunct for anesthesia to keep secretions controlled, anticholinesterase poisoning, bradycardia, GI hypermotility, cardiac arrest |
|
|
Term
Hyoscine is clinically used for: |
|
Definition
|
|
Term
Atropine methonitrate is clinically used for: |
|
Definition
|
|
Term
Ipratroprium is clinically used for: |
|
Definition
Asthma, bronchitis (antagonist for M3 mAChR) |
|
|
Term
Tropicamide and cyclopentolate are clinically used for: |
|
Definition
|
|
Term
|
Definition
Salivation, Lacrimation, Urination, Defecation, GI distress, Emesis |
|
|
Term
Most SLUDGE effects are through which receptors? |
|
Definition
|
|